<DOC>
	<DOCNO>NCT01420952</DOCNO>
	<brief_summary>Background : - ( 11C ) mGlu1 new drug help show protein , mGluR1 , find brain . The drug contain small amount radioactivity detect image study like positron emission tomography ( PET ) scan . By look mGluR1 receptor , researcher hope good understand involve general health , brain disorder , addiction . Objectives : - To test ( 11C ) mGlu1 distribute brain body . - To measure mGluR1 receptor display ( 11C ) mGlu1 image study . Eligibility : - Healthy volunteer 18 50 year age . Design : - Participants screen medical history , physical exam , blood urine test . This study require four visit NIH Clinical Center . - Participants initial evaluation , magnetic resonance imaging ( MRI ) scan , PET scan , final blood sample PET scan , different visit . - The MRI PET scan focus brain . Participants receive ( 11C ) mGlu1 , scan see show brain . - Some participant whole body image study see ( 11C ) mGlu1 show body .</brief_summary>
	<brief_title>Imaging Brain Receptors Using ( 11C ) mGlu1</brief_title>
	<detailed_description>Metabotropic glutamate receptor ( mGluRs ) G-protein coupled receptor respond glutamate activating protein inside nerve cell affect cell metabolism , thereby fine-tuning signal send cell maintain balance neuronal activity . mGluR receptor subtype 1 ( mGluR1s ) locate several brain region , include cerebellum , hippocampus , olfactory bulb , basal ganglion . mGluR1 activation stimulate phospholipase C , result phosphoinositide hydrolysis increase intracellular Ca ( 2+ ) level . Detailed study mGluR1s heretofore hinder lack high affinity selective ligand receptor subtype . The present protocol use new PET ligand [ C ( 11 ) ] mGlu1 1 ) perform kinetic brain image quantify mGluR1 bind parameter brain determine reliability reproducibility measure 15 healthy volunteer ( Phase 1 ) ; 2 ) tracer prove successful Phase 1 , estimate radiation-absorbed dos [ C ( 11 ) ] mGlu1 healthy human subject perform whole body imaging ( Phase 2 ) . Successful development PET ligand image mGlurR1 would strong impact clinical management brain disorder characterize disruption glutamatergic transmission , include anxiety stress disorder , drug addiction , epilepsy , Huntington disease , Parkinson disease .</detailed_description>
	<criteria>INCLUSION CRITERIA : Healthy volunteer subject age 18 50 medical history/physical exam , electrocardiogram ( ECG ) , laboratory test within normal limit within 60 day PET scan . EXCLUSION CRITERIA : &lt; TAB &gt; &lt; TAB &gt; Lifetime psychiatric illness severe systemic disease base history physical exam . &lt; TAB &gt; Serious medical illness likely modify brain anatomy and/or physiology ( seizure disorder , past brain surgery , etc . ) &lt; TAB &gt; High blood pressure , demonstrate least two rest measurement 140/100 , separate least 30 min . &lt; TAB &gt; Any current substance alcohol abuse , exception nicotine . &lt; TAB &gt; Positive urine toxicology screen &lt; TAB &gt; Radiation exposure participation research protocols clinical care last year additional radiation exposure protocol would exceed annual limit . &lt; TAB &gt; Pregnancy breastfeed . &lt; TAB &gt; Claustrophobia ( Part 1 ) . &lt; TAB &gt; metallic ( ferromagnetic ) implant , include pacemaker implant electrical device , brain stimulators , type dental implant , aneurysm clip ( metal clip wall large artery ) , metallic prosthesis ( include metal pin rod , heart valve , cochlear implant ) , permanent eyeliner , implanted delivery pump , shrapnel fragment , possible small metal fragment eye ( Part 1 ) . &lt; TAB &gt; Unable lie flat back 2.5 hour . &lt; TAB &gt; Positive HIV test . &lt; TAB &gt; Inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 27, 2012</verification_date>
	<keyword>Positron Emission Tomograhy ( PET )</keyword>
	<keyword>Metabolic Glutamate Receptors</keyword>
	<keyword>Brain</keyword>
</DOC>